Decision Making and Future Planning for Children With Complex Illness
1 other identifier
observational
32
1 country
3
Brief Summary
The population of children with life-limiting illnesses (LLI) in England is increasing and there is growing need to improve the quality of children's palliative care. Families of children with LLI are confronted with many care decisions for their children, such as whether and when to commence artificial nutrition or ventilation. They may also have the opportunity to consider the care that may be appropriate for their child in the future. Despite the important decisions families and professionals are required to make, there is little empirical evidence regarding the process of decision making and future planning for this population. Few studies have investigated the perspectives of multiple stakeholders and none have addressed multiple perspectives longitudinally. Therefore the relational and contextual aspects of decision making and future planning for children with LLI have as yet not been identified. A multiple embedded case study utilising ethnographic methods (semi-structured interviews, observation and notes review) is proposed to address this knowledge gap. Families of children with LLI cared for in either of two participating hospitals will be recruited and followed up for up to 12 months. The family will be invited to nominate 'significant others' (e.g. relatives, friends, health care professionals) who assist them in decision making and future planning, to participate in the study. Outpatient clinic appointments or ward rounds during periods of hospitalisation will be observed and semi-structured interviews will be conducted approximately three times with each participant. Medical notes will be reviewed at the end of the study. This research will enable a better understanding of the experiences and preferences for engaging in decision making and future planning from the perspectives of all stakeholders. It will also provide an awareness of the communication practices involved in discussions and the networks of care surrounding children with LLI, including specific support needs in relation to their role.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2015
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2015
CompletedStudy Start
First participant enrolled
October 1, 2015
CompletedFirst Posted
Study publicly available on registry
October 19, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2017
CompletedMay 3, 2017
May 1, 2016
1.3 years
July 31, 2015
May 2, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Semi-Structured Interview Responses
Interviews will be semi-structured, with a broad opening question asking the participant about the child at the centre of the case; both in terms of their illness and their context (family, personality, values and goals). Although the topics of decision making and future planning will be covered within the interview, the way in which these are initiated are likely to be different for each participant and asked in relation to the responses given to the opening question.
Up to 24 months
Observational fieldnotes
Observations will occur at clinic appointments and ward rounds and will aim to identify the communication processes involved in decision making and how each individual involved participates.
Up to 24 months
Study Arms (1)
Decision making cohort
Any people identified as being important within the network of care for children with life-limiting illnesses.
Interventions
Observation of clinic appointments and ward rounds if the child is admitted to hospital during the study period.
Semi-structured interviews will be conducted approximately 3 times during the study period with each participant.
The child's electronic medical record will be accessed periodically to identify any planned appointments or periods of hospitalisation and their medical notes will also be reviewed at the end of the study.
Eligibility Criteria
Each case will be centred around a child with a life-limiting illness and their parents who will have been identified as eligible by their usual care team. Additional significant others who are important in their decision making and future planning will be identified by the family and will ideally include at least one health professional. However, the composition of each case will be determined by the child and family and may involve only them. Nominated 'significant others' may include extended family, peers, ministers of religion, key workers etc.
You may qualify if:
- Their child must be between 28 days and 18 years old
- Their child must have a LLI within categories 2-4 (Association for Children with Life-threatening and Terminal Conditions and their Families, 2004) (see page 8)
- Child must be under the care of a consultant at either of the two NHS Trusts included in the study
- The parent must be aware of the child's LLI diagnosis
- Participants must speak English. This is both due to resource constraints and due to the sensitive topic such that difficulties in translating questions sensitively may cause greater distress to participants.
- Children will be classed as participants if their parent is a participant and consents to their child's medical notes being accessed.
- For children to participate in the interview component of the study, they must be over the age of 7 years and cognitively able to provide their own assent (or consent, if over 16 years old)
- Parents must have agreed to the child's participation if they are under 16 years old
- Participants must speak English or be able to communicate in some way using alternative or augmentative communication.
- Significant others must have been identified by the eligible child and/or parents as being important in their decision making and future planning
- Participants must speak English
- Participants must be over the age of 7 years and provide their own assent alongside parental consent (if under 16 years old) or provide consent if they are over the age of 16 years (in the case of a friend or sibling being nominated as a 'significant other').
You may not qualify if:
- Families and significant others of children with ACT Category 1 life-threatening illnesses (Conditions for which curative treatment may be feasible but can fail)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Sherwood Forest Hospitals NHS Trust
Mansfield, United Kingdom
Nottingham University Hospitals NHS Trust
Nottingham, United Kingdom
Sheffield Children's Hospital
Sheffield, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bridget Johnston, Professor
University of Nottingham
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2015
First Posted
October 19, 2015
Study Start
October 1, 2015
Primary Completion
January 31, 2017
Study Completion
January 31, 2017
Last Updated
May 3, 2017
Record last verified: 2016-05